Patents by Inventor Kyle DOOLAN

Kyle DOOLAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES DIRECTED TO CLAUDIN 6, INCLUDING BISPECIFIC FORMATS THEREOF
    Publication number: 20250145710
    Abstract: The disclosure is directed to an antibody specific for claudin 6 and CD3 and method of preparing and using the same. The present disclosure describes the isolation and characterization of antibodies, antibody fragments, and antibody variants specific for claudin 6 and CD3.
    Type: Application
    Filed: June 12, 2024
    Publication date: May 8, 2025
    Inventors: Joseph RUCKER, Kyle Doolan
  • Antibodies directed to claudin 6, including bispecific formats thereof
    Patent number: 12049502
    Abstract: The disclosure is directed to an antibody specific for claudin 6 and CD3 and method of preparing and using the same. The present disclosure describes the isolation and characterization of antibodies, antibody fragments, and antibody variants specific for claudin 6 and CD3.
    Type: Grant
    Filed: November 29, 2023
    Date of Patent: July 30, 2024
    Assignee: Integral Molecular, Inc.
    Inventors: Joseph Rucker, Kyle Doolan
  • ANTIBODIES DIRECTED TO CLAUDIN 6, INCLUDING BISPECIFIC FORMATS THEREOF
    Publication number: 20240174751
    Abstract: The disclosure is directed to an antibody specific for claudin 6 and CD3 and method of preparing and using the same. The present disclosure describes the isolation and characterization of antibodies, antibody fragments, and antibody variants specific for claudin 6 and CD3.
    Type: Application
    Filed: November 29, 2023
    Publication date: May 30, 2024
    Inventors: Joseph RUCKER, Kyle DOOLAN